Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|May 24, 2025
Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancerLiling Huang, Haohua Zhu, Liyuan Dai, et al.Journal of Translational Medicine|September 21, 2021
Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapyYu Zhou, Shasha Wang, Yunxia Tao, et al.International Journal of Cancer|May 14, 2020
Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroupShiyu Jiang, Yan Qin, Hongxin Jiang, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 19, 2014
Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphomaBo Jia, Yuankai Shi, Mei Dong, et al.Hematology (Amsterdam, Netherlands)|April 15, 2016
Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomasBo Jia, Shaoxuan Hu, Jianliang Yang, et al.Therapeutic Advances in Medical Oncology|September 15, 2025
Combination of immunotherapy-based systemic therapy and radiotherapy achieves durable response and favorable survival in recurrent head and neck cancerJingbo Wang, Gulidanna Shayan, Xin Guo, et al.BMJ Open|June 3, 2019
Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in ChinaShiyu Jiang, Peng Liu, Sheng Yang, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 7, 2015
Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphomaBo Jia, Yuankai Shi, Suyi Kang, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 27, 2015
Autologous hematopoietic stem cell transplantation in chemotherapy-sensitive lymphoblastic lymphoma: treatment outcome and prognostic factor analysisYouwu Shi, Shengyu Zhou, Xiaohui He, et al.Annals of Human Genetics|June 29, 2021
An epigenome-wide DNA methylation study of patients with COVID-19Shengyu Zhou, Jintao Zhang, Jiawei Xu, et al.Pageof 10